05/25/2020 | News release | Distributed by Public on 05/25/2020 05:14
We know immunocompromised individuals, like those living with myasthenia gravis (MG), an autoimmune, neuromuscular disease, are seeking information on how COVID-19 could impact their lives and treatment plans. UCB is participating in ongoing conversations with patient advocacy groups and physicians about what resources are most helpful for people living with MG and their caregivers.
We are also following the lead of organizations like the Myasthenia Gravis Foundation of America (MGFA), who are quickly adapting their events from in-person to virtual settings. This flexibility allows patients, caregivers and their healthcare providers (HCPs) to continue learning and sharing - while maintaining a healthy distance from each other.
Recently, UCB participated in the MGFA national conference, which was held in an online setting this year. The event featured a virtual exhibit hall and web-based education sessions related to clinical trials, treatments, awareness and tips for people living with MG.
UCB involvement included participation in the following events: